Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05243212
What this trial is testing

Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Sheba Medical Center 75
Testing effectiveness (Phase 2)Study completedNCT02500251
What this trial is testing

Belimumab Impacting Transplant Eligibility

Who this might be right for
Renal Transplant Rejection
E. Steve Woodle 11
Not applicableStudy completedNCT06323902
What this trial is testing

Autologous Platelet-rich Plasma as a Treatment for Macular Holes

Who this might be right for
Macular HolesMacular Hole of Left Eye (Disorder)Macular Hole of Right Eye (Disorder)
Clinica Oftalmologica Paredes 13
Not applicableUnknownNCT03328728
What this trial is testing

Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Regen Lab SA 190
Testing effectiveness (Phase 2)UnknownNCT05998928
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Not applicableNot Yet RecruitingNCT07730645
What this trial is testing

Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2 (CIN2)Cervical Intraepithelial Neoplasia Grade 2CIN2
University Hospital Tuebingen 264
Testing effectiveness (Phase 2)Study completedNCT00547365
What this trial is testing

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
University of Tennessee 10
Testing effectiveness (Phase 2)Looking for participantsNCT05093075
What this trial is testing

Therapeutic Plasma Exchange in Septic Shock: A Pilot Study

Who this might be right for
Septic Shock
University of Manitoba 80
Large-scale testing (Phase 3)Study completedNCT00222053
What this trial is testing

IFM 99-02 Thalidomide in Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 800
Early research (Phase 1)Ended earlyNCT04614636
What this trial is testing

FT538 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAML, AdultMultiple Myeloma+1 more
Fate Therapeutics 42
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Not applicableStudy completedNCT02140463
What this trial is testing

Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)

Who this might be right for
Metastatic Gastrointestinal CancerGenitourinary Cancer
Samsung Medical Center 229
Not applicableStudy completedNCT02306928
What this trial is testing

PK Analysis of Piperacillin in Septic Shock Patients

Who this might be right for
Septic Shock
University of Aarhus 15
Not applicableUnknownNCT04365439
What this trial is testing

Convalescent Plasma for COVID-19

Who this might be right for
Blood Plasma TherapyCOVID
Enos Bernasconi 11
Not applicableUnknownNCT03436134
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

Who this might be right for
Kidney TransplantationAntibody Mediated Rejection
University Hospital, Grenoble 16
Not applicableLooking for participantsNCT06933277
What this trial is testing

Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients

Who this might be right for
Multiple Myeloma
Gruppo Italiano Malattie EMatologiche dell'Adulto 159
Post-approval studies (Phase 4)Study completedNCT02984228
What this trial is testing

Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis

Who this might be right for
OsteoarthritisShoulder Pain
Hospital for Special Surgery, New York 70
Not applicableStudy completedNCT01475409
What this trial is testing

A Study on Changes in IFN-gamma Levels Following Anti-TNF Treatment in Patients Undergoing Serial QuantiFERON-TB Gold In-Tube

Who this might be right for
Inflammatory Rheumatic Diseases
University of Roma La Sapienza 119
Not applicableStudy completedNCT03043638
What this trial is testing

Efficiency of PRP on Acellular Dermal Matrix Application in the Treatment of Multiple Adjacent Gingival Recessions

Who this might be right for
Gingival Recession, Generalized
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization 12
Next Page